Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership8,016,353 shares
Latest Disclosed Value $ 28,137,399
D. E. Shaw & Co., Inc. ownership in IOVA / Iovance Biotherapeutics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 8,016,353 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $28,137,399 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,829,795 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 109.32% during the quarter. The current value of the position is $30,381,978 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (IOVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IOVA / Iovance Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,016,353 4,186,558 109.32 28,137 169.12 0.0169
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 3,829,795 3,753,586 4,925.38 10,455 6,236.36 0.0057
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 76,209 20,738 37.39 165 73.68 0.0001
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 55,471 16,195 41.23 95 -26.92 0.0001
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 39,276 8,464 27.47 131 -42.98 0.0001
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 30,812 -36,936 -54.52 228 -64.15 0.0002
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 67,748 -588,082 -89.67 636 -87.91 0.0005
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 655,830 -1,696,336 -72.12 5,260 -84.91 0.0049
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,352,166 2,137,032 993.35 34,859 1,893.08 0.0298
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 215,134 177,372 469.71 1,749 922.81 0.0015
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 37,762 -820,994 -95.60 172 -97.17 0.0002
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 858,756 -1,501,195 -63.61 6,046 -58.08 0.0062
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,359,951 -1,861,809 -44.10 14,419 -46.55 0.0154
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 4,221,760 1,526,540 56.64 26,977 4.48 0.0298
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,695,220 617,689 29.73 25,820 12.57 0.0308
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,077,531 1,952,904 1,567.00 22,936 1,005.35 0.0269
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 124,627 52,590 73.00 2,075 50.91 0.0019
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 72,037 62,523 657.17 1,375 485.11 0.0011
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,514 -16,072 -62.82 235 -64.71 0.0002
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 25,586 -212,183 -89.24 666 -91.15 0.0006
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 237,769 108,988 84.63 7,528 25.97 0.0073
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 128,781 82,391 177.61 5,976 291.36 0.0053
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 46,390 46,390 -63.98 1,527 -74.45 0.0016
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -26,715 -100.00 0 -100.00
2020-05-15 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 26,715 4,526 20.40 800 30.29 0.0012
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 22,189 22,189 -16.94 614 -23.25 0.0007
2019-02-14 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -22,754 -100.00 0 -100.00
2018-11-14 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 22,754 22,754 256 0.0003
2017-05-15 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 0 -14,778 -100.00 0 -100.00
2017-02-14 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 14,778 14,778 0.00 103 0.0002
2016-08-15 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 0 -17,176 -100.00 0 -100.00
2016-05-16 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 17,176 3,282 23.62 87 -18.69 0.0002
2016-02-16 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 13,894 -3,854 -21.72 107 4.90 0.0002
2015-11-16 2015-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 17,748 -6,159 -25.76 102 -53.42 0.0002
2015-08-14 2015-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 23,907 23,907 219 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 22,800 -67.15 183 -82.30 n/a n/a n/a
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 69,400 1,029 n/a n/a n/a
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 20,000 -50.00 549 -54.14 n/a n/a n/a
2020-05-15 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 40,000 1,197 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 84,200 1,248 n/a n/a n/a
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 30,500 0.00 582 -22.61 n/a n/a n/a
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 30,500 0.00 752 -5.29 n/a n/a n/a
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 30,500 794 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.